The answer to this question is affirmative what finds its legitimacy in Article 180 §2 of the Polish Commercial Companies Code. This possibility was implemented into the Polish legislation through the amendment of the Commercial Companies Code of 2016. However, in order to be able to speak of an effective transfer of shares in the discussed e-form, the following three conditions must be met:

More

Facial recognition technology has gained popularity among companies as a means of monitoring activities for security purposes and confirming the identity of customers. The European Commission has proposed new regulations on the use of artificial intelligence technologies. The regulations are designed to support innovations, such as the use of AI to improve production, forecast climate change and increase user confidence in new generation products with versatile applications.

On the other hand, the use of technologies harmful to the citizens of the European Union, violating their right to privacy, is to be prohibited or subject to restrictions. The proposal is based on a ban on the use of real-time facial recognition by law enforcement, with exceptions. Another assumption is also to prohibit the use of certain types of artificial intelligence systems. The body of the European Union proposed the introduction of a new law that would regulate the issue of using artificial intelligence.

More

Medical Research Agency

The Medical Research Agency (MRA) is a Polish state agency, which tasks include development of scientific research in the field of medical and health sciences. Its main goal is to build an innovative healthcare system, which will contribute to a better way of meeting society’s needs through assessing which new medical technologies and therapeutic methods should be used.

Currently, the Agency implements one of the first public grant programmes that finances non-commercial clinical trials in Poland. The Agency has planned five calls for proposals for the year 2021 – two which have recently closed, concerning clinical research in rare diseases and creating and further developing Clinical Research Support Centres, and three which details are yet to be announced, concerning clinical research in psychiatry and neurology (second quarter of 2021), development of innovative therapeutic solutions that use the RNA technology (may 2021) and prevention and curing of civilisation diseases (third quarter of 2021).

Clinical Research Development Centre

The development of aforementioned Clinical Research Support Centres is one of the projects of the Clinical Research Development Centre (CRDC). The main goal of CRDC is to initiate and support the activities that aim to remove the barriers in clinical research development in Poland. From its beginnings, The Centre has been analysing and defining the scope and direction of changes to optimise the clinical research market in Poland and supporting the development of said research.

More

The Krakow office of KIEŁTYKA GŁADKOWSKI KG Legal received an invitation to the jubilee seminar on the occasion of the 25th anniversary of Deutsch – Niederländische Rechtsanwaltsvereinigung, due to the membership of one of the law firm’s managing partners (Jakub Gładkowski) in this organization.Due to the pandemic, an international jubilee seminar is scheduled for May 2022 at Schloss Krickenbeck in Nettetal (North Rhine-Westphalia, Germany).

The Managing Partners of KIEŁTYKA GŁADKOWSKI KG LEGAL would like to express their best wishes and congratulations to the management board of DNRV, including especially Att. Ute Acker, Arjen Westerdijk, Regine Nuckel, Anton Bouwmeister, Alexander Sanio on this great jubilee.
The invitation was accompanied by a specially wrapped bar of Belgian chocolate from a Dutch manufacture, which engages in useful social campaigns.

A sweet gift from the Netherlands helps a lot in the pandemic, especially on a rainy day by the Polish Vistula in Krakow!

More

On 20 – 22 April, 2021 KG Legal founding partners, Małgorzata Kiełtyka and K. Jakub Gładkowski are participating in the Conference The health + wealth of America initiative held.

More